Keyphrases
Breast Cancer Cells
100%
Epithelial-mesenchymal Transition
100%
Interleukin-6
100%
Nuclear factor-κB
100%
JAK2-STAT3 Pathway
100%
Azilsartan
100%
Colony Formation
33%
MRNA Level
33%
Antiproliferative Activity
33%
JAK2-STAT3
33%
Apoptosis
16%
Induced Apoptosis
16%
Signaling Pathway
16%
Cell Viability
16%
Molecular Mechanism
16%
Western Blot Analysis
16%
Quantitative PCR
16%
Cell Cycle Arrest
16%
Matrix metalloproteinase-9 (MMP-9)
16%
Cell Migration Ability
16%
MDA-MB-231
16%
Tumor Cell Proliferation
16%
Tumor Metastasis
16%
Mesenchymal-epithelial Transition Factor
16%
Metastatic Breast Cancer
16%
Apoptotic Pathway
16%
Angiotensin II (Ang II)
16%
Cancer Cell Survival
16%
Cell Migration Assays
16%
MCF-7 Cancer Cell Line
16%
B-cell Lymphoma 2 (Bcl-2)
16%
Breast Cancer
16%
Anti-migration
16%
Inhibition Activity
16%
Bcl-2 Family Proteins
16%
Viability Cell
16%
Cleaved caspase-3
16%
Caspase-3 Protein
16%
STAT3 Protein
16%
Angiotensin Receptor Blockers
16%
MMP-9 Gene
16%
Biochemistry, Genetics and Molecular Biology
Cancer Cell
100%
Interleukin 6
100%
Mesenchymal-Epithelial Transition
100%
STAT3
100%
Janus Kinase
100%
Cell Migration
40%
Colony Formation
40%
Signal Transduction
40%
Gelatinase B
40%
MMP9
40%
Messenger RNA
40%
Poly ADP Ribose Polymerase
20%
Tumor Progression
20%
Reverse Transcription Polymerase Chain Reaction
20%
Cell Cycle Arrest
20%
Cell Cycle
20%
Cell Viability
20%
Cell Survival
20%
Caspase 3
20%
Antiproliferative Activity
20%
Angiotensin Receptor
20%
Cell Cycle Checkpoint
20%
Western Blotting
20%
Angiotensin
20%
Immunology and Microbiology
Cancer Cell
100%
Interleukin 6
100%
Epithelial Mesenchymal Transition
100%
STAT3
100%
Colony Formation
50%
Cell Migration
50%
Signal Transduction
50%
Western Blot
25%
Tumor Cell
25%
Caspase
25%
Cell Survival
25%
Cell Viability
25%
Breast Cancer Cell Line
25%
Cell Growth
25%
Cell Cycle Arrest
25%
Cell Cycle
25%
Reverse Transcription Polymerase Chain Reaction
25%
Antiproliferative Activity
25%
Cell Cycle Checkpoint
25%
Pharmacology, Toxicology and Pharmaceutical Science
Breast Cancer
100%
Interleukin 6
100%
Azilsartan
100%
Janus Kinase
100%
Gelatinase B
33%
STAT3 Protein
33%
Messenger RNA
33%
Malignant Neoplasm
16%
Western Blot
16%
Cell Viability
16%
Tumor Growth
16%
Angiotensin II
16%
Caspase 3
16%
Antiproliferative Activity
16%
Janus Kinase 2
16%
Angiotensin Receptor Antagonist
16%
Metastatic Breast Cancer
16%
Apoptosis
16%